|
Summary Information: Certara Inc. Common Stock NASDAQ:CERT |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Certara optimizes R&D productivity, commercial value and patient outcomes through its unique portfolio of model-informed drug development, regulatory science, and market access solutions. In fact, 90+% of all novel drugs approved by the US FDA in the past six years were supported by Certara software or services. Its clients include 1,600 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.
__The following are links to various summary and news pages for __Certara Inc. Common Stock [ CERT ]. __Note: Some Links might not have information for the company. |
|